A new class of selective and potent inhibitors of neuronal nitric oxide synthase.
暂无分享,去创建一个
R. Volkmann | J. Lowe | M. Ashton | S. Zorn | R. Nelson | W. S. Faraci | M. Sanders | M. Stefaniak | D. Liston | C. Nolan | S. Heck | K. Ward | W. Qian | S. Doran | C. Johnson | K. Verdries | J. Nowakowski | P. Whittle | J. Baxter | M. Vanase
[1] M. Salter,et al. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. , 1998, Journal of medicinal chemistry.
[2] D. Rousseau,et al. NO synthase isozymes have distinct substrate binding sites. , 1997, Biochemistry.
[3] T. Billiar. Nitric Oxide Novel Biology with Clinical Relevance , 1995, Annals of surgery.
[4] S. L. Hart,et al. Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects , 1993, British journal of pharmacology.